DE60210313D1 - Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung - Google Patents

Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung

Info

Publication number
DE60210313D1
DE60210313D1 DE60210313T DE60210313T DE60210313D1 DE 60210313 D1 DE60210313 D1 DE 60210313D1 DE 60210313 T DE60210313 T DE 60210313T DE 60210313 T DE60210313 T DE 60210313T DE 60210313 D1 DE60210313 D1 DE 60210313D1
Authority
DE
Germany
Prior art keywords
reduce
indications
skin aging
extract
date core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210313T
Other languages
English (en)
Other versions
DE60210313T2 (de
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE SA) BIOT Ste
Vincience SA
Original Assignee
D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE SA) BIOT Ste
Societe dExtraction des Principes Actifs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE SA) BIOT Ste, Societe dExtraction des Principes Actifs SA filed Critical D'EXTRACTION DES PRINCIPES ACTIFS (VINCIENCE SA) BIOT Ste
Publication of DE60210313D1 publication Critical patent/DE60210313D1/de
Application granted granted Critical
Publication of DE60210313T2 publication Critical patent/DE60210313T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DE60210313T 2001-08-07 2002-07-29 Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung Expired - Lifetime DE60210313T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0110528 2001-08-07
FR0110528A FR2828399B1 (fr) 2001-08-07 2001-08-07 Utilisation d'un extrait de dattes pour traiter les manifestations cutanees du vieillissement
PCT/FR2002/002718 WO2003013463A1 (fr) 2001-08-07 2002-07-29 Utilisation d'un extrait de noyaux de dattes pour traiter le vieillissement cutane

Publications (2)

Publication Number Publication Date
DE60210313D1 true DE60210313D1 (de) 2006-05-18
DE60210313T2 DE60210313T2 (de) 2006-12-14

Family

ID=8866336

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210313T Expired - Lifetime DE60210313T2 (de) 2001-08-07 2002-07-29 Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung

Country Status (5)

Country Link
EP (1) EP1414404B1 (de)
AT (1) ATE321528T1 (de)
DE (1) DE60210313T2 (de)
FR (1) FR2828399B1 (de)
WO (1) WO2003013463A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039631A1 (de) 2004-08-11 2006-03-02 Lancaster Group Gmbh Pigmenthaltiges kosmetisches Mittel mit Anti-Alterungswirkung für die Haut
FR2883183B1 (fr) * 2005-03-16 2009-01-16 Soc Extraction Principes Actif Utilisation d'un extrait de dattes en tant qu'agent anti-oxydant
DE102006013925A1 (de) * 2006-03-21 2007-09-27 Lancaster Group Gmbh Kosmetikum zur nachhaltigen Behandlung tieferer Hautfalten
JP2015505243A (ja) 2011-12-20 2015-02-19 ザ プロクター アンド ギャンブルカンパニー 皮膚色素沈着を引き起こす機構についての仮説を検証するためのヒト皮膚サンプリング方法及びモデル

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442961C1 (de) * 1984-11-24 1985-08-14 Manfred Kriwet Haarpflegemittel
FR2687310A1 (fr) * 1992-02-19 1993-08-20 Gaillard Eric Dentifrice comestible.
FR2712601B1 (fr) * 1994-03-03 1995-12-29 Arkopharma Laboratoires Jus et suspension de fruits, leur procédé de préparation et leurs applications.
JPH09249578A (ja) * 1996-03-18 1997-09-22 Yakurigaku Chuo Kenkyusho:Kk チロシナーゼ賦活作用を指標とする生薬抽出物の臨床応用
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
CN1243819A (zh) * 1999-01-15 2000-02-09 高福兴 天然果酸及天然果酸的制造工艺

Also Published As

Publication number Publication date
EP1414404B1 (de) 2006-03-29
WO2003013463A1 (fr) 2003-02-20
DE60210313T2 (de) 2006-12-14
EP1414404A1 (de) 2004-05-06
FR2828399B1 (fr) 2005-06-17
ATE321528T1 (de) 2006-04-15
FR2828399A1 (fr) 2003-02-14

Similar Documents

Publication Publication Date Title
ATE362387T1 (de) Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
EP1545587A4 (de) Lactoferrin-zusammensetzungen und wundbehandlungsverfahren
ATE303156T1 (de) Verwendung von gnrh-analogue zur behandlung der harninkontinenz
BR0306665A (pt) Uso de zeìna nativa para aperfeiçoamento do estado do cabelo e agentes
MEP8209A (en) Modified factor viii
ATE295735T1 (de) Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs
MY137828A (en) Keratinocytes which may be used as a biologically active substances for the treatment of wounds
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
MXPA05000073A (es) Uso de isoflavonas para preparar composiciones topicas para promover el adelgazamiento, y metodo de tratamiento cosmetico relacionado.
DE60210313D1 (de) Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung
MXPA05011830A (es) Peptidos para uso en el tratamiento de la obesidad.
ATE486567T1 (de) Orale zusammensetzung mit einer ersten zusammensetzung (a) und einer zweiten zusammensetzung (b) zur verwendung als gemische zur getrennten oder aufeinanderfolgenden verwendung in der kosmetischen behandlung des menschlichen körpers
WO2005053728A3 (de) Mit adipositas assoziierte proteine und deren verwendung in therapie und diagnostik
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE281165T1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
RS95304A (en) New combination fortreating airway disorders
WO2002034210A3 (fr) Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement
DE50202331D1 (de) Verwendung eines phosphatadsorbers gegen gefässerkrankungen
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
ATE283693T1 (de) Verwendung von pregabalin zur asthma behandlung
DE69904297D1 (de) Neue verwendung von ropivacain zur schmerzbehandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition